Test from C2N Diagnostics is meant for people 60 years and older who have cognitive issues and are being assessed for Alzheimer disease
Decline in SARS-CoV-2 Antibody Response Seen Over 60 Days
More than one in four health care personnel who were positive for SARS-CoV-2 antibodies were seronegative on repeat testing
Risk for Bone Fractures Up for Patients With Psoriatic Diseases
No difference in bone mineral density and no increased risk for osteoporosis seen for psoriatic disease patients versus controls
CVD Risk Higher in T2DM Even With Optimal Risk Factor Management
Those with T2DM with optimal risk factor control have greater risk for cardiovascular disease events versus those without T2DM
ART Treatment Not Tied to Higher Risk for Ovarian Cancer
Increased risk compared with general population likely due to nulliparity among ART-treated women; risk not increased versus subfertile women
Canagliflozin Beneficial Even for Advanced Kidney Disease
Canagliflozin slows progression of kidney disease in participants with eGFR <30 mL/min/1.73 m2 with no increase in AKI
Breast Cancer, CRC Incidence No Different With, Without MS
However, bladder cancer incidence and mortality rates higher among individuals with multiple sclerosis
Prognosis Good With Negative Biopsy in Active Surveillance
Negative biopsies during active surveillance for low-risk prostate cancer tied to more favorable outcomes
CT Use Down for ED Evaluation of Abdominal Pain in Children
Among adults with abdominal pain, use of CT in emergency department consistently increased from 1997 to 2016
COVID-19 Outcomes Not Improved With Convalescent Plasma
Clinical status, mortality did not differ for convalescent plasma versus placebo in adults with severe COVID-19 pneumonia